Onkologie. 2021:15(3):127-130 | DOI: 10.36290/xon.2021.024

Palliative surgery and intervention procedures in selected conditions in gynecologic oncology

Magdalena Plch, Gabriel Jelenek, Josef Chovanec
Oddělení gynekologické onkologie Kliniky operační onkologie, Masarykův onkologický ústav a LF MU v Brně

Advanced gynecologic malingnancies can result in conditions, which strong determine the quality of life of patients and their family. In situations, when curative cancer treatment is no longer indicated and the therapy is focused on the symptomatic relief, besides the pharmacotherapy and care, intervention procedures can be used after a careful evaluation of the indication. This article brings a overview of possibilities of palliative surgery and intervention procedures in selected conditions in gynecologic oncology.

Keywords: advanced gynecologic malingnancies, palliative therapy, acute conditions.

Published: May 6, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Plch M, Jelenek G, Chovanec J. Palliative surgery and intervention procedures in selected conditions in gynecologic oncology. Onkologie. 2021;15(3):127-130. doi: 10.36290/xon.2021.024.
Download citation

References

  1. Sláma O, Kabelka L, Vorlíček J, et al. Palitativní medicína pro praxi. Praha: Galén 2011: 363s.
  2. Ferguson HJ, Ferguson CI, Speakman J, Ismail T. Management of intestinal obstruction in advanced malignancy. Ann Med Surg (Lond). 2015; 4(3): 264-270. Published 2015 Aug 1. doi:10.1016/j.amsu.2015.07.018. Go to original source... Go to PubMed...
  3. Slováček L, Filip S, Slováčková B, Slánská I, Priester P. Vybrané akutní stavy u nemocných zařazených do programu paliativní onkologické péče. Onkologie 2012; 6(2): 85-89.
  4. Ripamonti C, Twycross R, Baines M, Bozzetti F, Capri S, De Conno F, Gemlo B, Hunt TM, Krebs HB, Mercadante S, Schaerer R, Wilkinson P. Working Group of the European Association for Palliative Care. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer. 2001; 9(4): 223-33. doi: 10.1007/s005200000198. PMID: 11430417. Go to original source... Go to PubMed...
  5. Cousins SE, Tempest E, Feuer DJ. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2016; 2016(1): CD002764. doi: 10.1002/14651858.CD002764.pub2. PMID: 26727399; PMCID: PMC7101053. Go to original source... Go to PubMed...
  6. Henry JC, Pouly S, Sullivan R, Sharif S, Klemanski D, Abdel-Misih S, Arradaza N, Jarjoura D, Schmidt C, Bloomston M. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery. 2012; 152(4): 747-56; discussion 756-7. doi: 10.1016/j.surg.2012.07.009. Epub 2012 Aug 26. PMID: 22929404; PMCID: PMC3792226. Go to original source... Go to PubMed...
  7. Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011; 254(2): 333-338. doi: 10.1097/SLA.0b013e31822513ed. PMID: 21677562. Go to original source... Go to PubMed...
  8. Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg. 2014; 149(4): 383-392. doi: 10.1001/jamasurg.2013.4059. PMID: 24477929; PMCID: PMC4030748. Go to original source... Go to PubMed...
  9. Laval G, Marcelin-Benazech B, Guirimand F, Chauvenet L, Copel L, Durand A, Francois E, Gabolde M, Mariani P, Rebischung C, Servois V, Terrebonne E, Arvieux C; French Society for Palliative Care; French Society for Digestive Surgery; French Society for Gastroenterology; French Association for Supportive Care in Oncology; French Society for Digestive Cancer. Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manage. 2014; 48(1): 75-91. doi: 10.1016/j.jpainsymman.2013.08.022. Epub 2014 May 4. PMID: 24798105. Go to original source... Go to PubMed...
  10. van Hooft JE, van Halsema EE, Vanbiervliet G, Beets-Tan RG, DeWitt JM, Donnellan F, Dumonceau JM, Glynne-Jones RG, Hassan C, Jiménez-Perez J, Meisner S, Muthusamy VR, Parker MC, Regimbeau JM, Sabbagh C, Sagar J, Tanis PJ, Vandervoort J, Webster GJ, Manes G, Barthet MA, Repici A; European Society of Gastrointestinal Endoscopy. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2014; 46(11): 990-1053. doi: 10.1055/s-0034-1390700. Epub 2014 Oct 17. PMID: 25325682. Go to original source... Go to PubMed...
  11. Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, Kuipers EJ, Siersema PD; Dutch SUSTENT Study Group. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010; 71(3): 490-499. doi: 10.1016/j.gie.2009.09.042. Epub 2009 Dec 8. PMID: 20003966. Go to original source... Go to PubMed...
  12. Holmes C, Mitchell A. Palliative care in gynaecological oncology. Review. Obstetrics, Gynaecology and Reproductive Medicine. [online]. 2017; 27: p. 297-302. Dostupné z: https://doi.org/10.1016/j.ogrm.2017.07.001. Go to original source...
  13. Eleje GU, Eke AC, Igberase GO, Igwegbe AO, Eleje LI. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. Cochrane Database of Systematic Reviews. 2019. [online]. Mar 19; 3: CD011000. Dostupné z: doi: 10.1002/14651858.CD011000.pub3. Go to original source... Go to PubMed...
  14. Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Review. Annals of Palliative Medicine 2018. [online]. 2018; 7 (2): 265-273. Go to original source... Go to PubMed...
  15. Arnold MJ, Keung J, McCarragher B. Interventional Radiology: Indications and Best Practices. American Family Physician. 2019; 9:547-556.
  16. Fleming ND, Alvarez-Secord A, Von Gruenigen V, Miller MJ, Abernethy AP. Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review. J Pain Symptom Manage. 2009; 38(3): 341-9. doi: 10.1016/j.jpainsymman.2008.09.008. Epub 2009 Mar 28. PMID: 19328648. Go to original source... Go to PubMed...
  17. Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016; 1(3): 231-238. doi: 10.1080/23809000.2016.1185369. Epub 2016 May 27. PMID: 30906877; PMCID: PMC6425954. Go to original source... Go to PubMed...
  18. Reynolds TB. Renaissance of paracentesis in the treatment of ascites. Adv Intern Med. 1990; 35: 365-73.
  19. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez Panadero F, Sahn SA. Management of malignant pleural effusions. Eur Respir J. 2001; 18(2): 402-419. doi: 10.1183/09031936.01.00225601. PMID: 11529302. Go to original source... Go to PubMed...
  20. Antunes G, Neville E, Duffy J, Ali N; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003; 58 Suppl 2(Suppl 2): ii29-38. doi: 10.1136/thorax.58.suppl_2.ii29. PMID: 12728148; PMCID: PMC1766015. Go to original source... Go to PubMed...
  21. Neto JD, de Oliveira SF, Vianna SP, Terra RM. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions. Respirology 2010 Jan; 15(1): 115-8. doi: 10.1111/j.1440-1843.2009.01663.x. Epub 2009 Nov 23. PMID: 19947987. Go to original source... Go to PubMed...
  22. Patel K, Foster NR, Kumar A, et al. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015; 23(5): 1303-1309. doi:10.1007/s00520-014-2482-y Go to original source... Go to PubMed...
  23. Holmes C, Mitchell A. Palliative care in gynaecological oncology. Review. Obstetrics, Gynaecology and Reproductive Medicine. [online]. 2017; 27: 297-302. Dostupné z: https://doi.org/10.1016/j.ogrm.2017.07.001. Go to original source...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.